EPL Limited has delivered a blockbuster performance in the second quarter of FY27, posting a 30% year-on-year jump in revenue to Rs 15,674 million, as strong growth across geographies and product categories powered its business despite global market volatility and geopolitical disruptions.

 

The global packaging solutions major reported underlying revenue growth of 20.3%, excluding the impact of higher raw material prices, underscoring the strength of its business model, customer relationships and execution strategy.

 

Growth was broad-based, with all regions recording double-digit expansion. Beauty & Cosmetics led the charge with a striking 42.9% growth, while Oral Care continued its strong momentum.

 

The quarter also marked a significant milestone in EPL's portfolio transformation, with Beauty & Cosmetics overtaking Oral Care in September to become the company's largest category.

 

EPL's EBITDA rose 17.6% year-on-year to Rs 2,960 million, marking its 16th consecutive quarter of double-digit EBITDA growth.

 

Reported EBITDA margin stood at 18.9%, while underlying EBITDA margin remained firm at 20.4%. The company said it successfully recovered the full impact of higher costs through judicious pricing across all regions.

 

Profit after tax (PAT) increased 5.6% to Rs 1,101 million, reflecting the company's ability to balance investments in growth with profitability. Return on Capital Employed (ROCE) remained strong at 18.2%.

 

Hemant Bakshi, MD & Global CEO, EPL Limited, said, “EPL has delivered another standout quarter, achieving 30% revenue growth, on an underlying basis revenue growth was 20% and margins were 20.4%. What makes this performance particularly meaningful is that our strategy is delivering in full across every geography and core category. 

 

"Beauty & Cosmetics delivered exceptional growth of over 40%, while Oral Care continued its strong momentum with 20% growth. In the month of September, B&C category overtook Oral care to become our largest category, a significant milestone towards building a fully diversified, high growth portfolio. 

 

"Despite continued cost pressures, we successfully recovered the full impact of cost increases through pricing actions, enabling us to sustain underlying EBITDA margins above 20% while continuing to invest in our growth priorities. Looking ahead, we remain confident in our momentum and confidently reaffirm our near-term guidance of high-teens revenue growth and 20% underlying EBITDA margins”.

 

EPL's geographic performance reflected the strength of its diversified global footprint, with every region delivering robust double-digit revenue growth.

 

East Asia Pacific (EAP) led with 40.2% growth, followed by Europe at 30.4%, AMESA at 28% and the Americas at 25.3%. India posted a strong 30.5% growth within the AMESA region.

 

At the category level, Beauty & Cosmetics expanded 42.9%, while Oral Care grew 19.2%, maintaining its strong market position. Personal Care & Beyond now accounts for 55% of EPL's total portfolio, highlighting the company's accelerating shift towards a more diversified, high-growth business.

 

EPL continued to strengthen its sustainability credentials, with sustainable tube formats accounting for 41% of total sales year-to-date.

 

The company retained its EcoVadis Platinum certification, placing it among the top 1% of more than 150,000 companies assessed globally.

 

Its focus on innovation and quality also earned recognition at the IFCA Star Awards 2026 and Print Week 2026. Meanwhile, EPL's operations across seven countries — India, Poland, Egypt, the Philippines, Colombia, China and Brazil — continued to hold Great Place to Work certification for FY25-26.

 

In a significant strategic development, EPL's proposed merger with Indovida advanced further, marking an important step towards its ambition of building a leading consumer packaging business in emerging markets.

 

The proposed merger is expected to create an entity with revenue of $1 billion and a valuation of $2 billion.

 

Following approvals from the Competition Commission of India (CCI), stock exchanges and foreign anti-trust authorities across 10 jurisdictions, EPL filed its application with the Hon'ble National Company Law Tribunal (NCLT), Mumbai, on October 23, 2026. The BSE and NSE issued their observation letters on October 19, 2026.

 

The company remains confident of completing the merger within the expected timelines.

 

Looking ahead, EPL remains focused on navigating global uncertainties through operational discipline, pricing measures and continued investment in growth opportunities.

 

The company has reaffirmed its near-term guidance of high-teens revenue growth over the next few quarters, alongside an underlying EBITDA margin target of 20%.

 

Strengthening its leadership in Beauty & Cosmetics, accelerating growth in emerging markets, improving capital efficiency and expanding beyond tubes into broader consumer packaging platforms will remain central to its growth strategy.